The Australia general surgery devices market size is projected to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the high incidences of cardiac diseases, increasing demand for surgeries, rising awareness among patients, and surge in geriatric population. Affordability of patients for the reconstructive and plastic surgeries is expected to fuel the market in the coming years.
General surgery devices are the tools used to aid the physical modification of the tissues that are biological and also helps to give access to the internal bodies. It is evolved as a sophisticated means for the improvement of the patient outcomes. At the time of surgery, the instruments that emit energy including ultrasonic waves, high frequencies, and microwaves are used accordingly. The generic term used for the surgical instruments is surgical energy devices.
The energy produced by the devices interacts with the living tissues to turn them into heat that cuts the organs and tissues to stop bleeding from incision. Surgery devices are used to execute various tasks such as dissecting, holding, suturing, cutting, grasping, and retracting. These devices are made up of stainless steel as well as different metals such as chromium, molybdenum, titanium, and vanadium. Establishment of modern electronic technology for surgery such as power assisted systems and minimally invasive surgery devices is anticipated to boost the market growth of the Australia general surgery devices.
Market Trends, Drivers, Restraints, and Opportunities
- Growing preference for robotic and computer assisted surgeries is expected to propel the market expansion during the forecast period.
- Rapid growth of the hospital industry is major factors driving the market growth in the coming years.
- Inadequate quality assurance regarding performance is estimated to hamper the market expansion during the forecast period.
- Improper sterilization steps for the reusable devices acts as main challenge that can hinder the market growth in the coming years.
- R&D investment and technological advancement in surgery devices is anticipated to offer significant opportunities for the market players.
Scope of the Report
The report on the Australia general surgery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
General Surgery Devices Market - Australia Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Products (Laproscopic Devices, Wound Closure Devices, Handheld Devices, Electro Surgical Devices, Trocars & Access Devices, and Others), Applications (Cardiology, Neurology, Gynecology, Orthopaedic, Urology, and Others)
|
|
Country
|
Australia
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Boston Scientific Corporation; Medtronic Plc.; B.Barun Melsungen AG; Conmed Corporation; Johnson & Johnson Services, Inc.; 3M Healthcare; Integra LifeSciences; Erbe Elektromedizin GmbH; and Smith & Nephew
|
Market Segment Insights:
Laproscopic devices segment is projected to account for a large market share
Based on products, the Australia general surgery devices market is divided into laproscopic devices, wound closure devices, handheld devices, electro surgical devices, trocars & access devices, and others. The laproscopic devices segment is expected to constitute a key share of the market during the forecast period owing to reduced trauma to skin & muscles, quick recovery, and decreased infection rate. However, the handheld devices segment is anticipated to expand at a rapid pace during the forecast period due to its portability, faster access to patients, and improves medication adherence.
Orthopaedic segment is projected to hold a key market share
On the basis of applications, the market is segmented into cardiology, neurology, gynecology, orthopaedic, urology, and others. The orthopaedic segment is expected to represent a key share of the market in the coming years due to rising geriatric population and growing cases of bone diseases. On the other hand, the other segment is anticipated to expand at a rapid pace during the forecast period owing to increasing cases of road accidents, rising number of centers to improve treatment, and advancement in technologies.
Segments
Segments Covered in the Report
The Australia general surgery devices market has been segmented on the basis of
Products
- Laproscopic Devices
- Wound Closure Devices
- Handheld Devices
- Electro Surgical Devices
- Trocars & Access Devices
- Others
Applications
- Cardiology
- Neurology
- Gynecology
- Orthopaedic
- Urology
- Others
Country
Key Players
- Boston Scientific Corporation
- Medtronic Plc.
- B. Barun Melsungen AG
- Conmed Corporation
- Johnson & Johnson Services, Inc.
- 3M Healthcare
- Integra LifeSciences
- Erbe Elektromedizin GmbH
- Smith & Nephew
Competitive Landscape
Key players competing in the Australia general surgery devices market include Boston Scientific Corporation; Medtronic Plc.; B. Barun Melsungen AG; Conmed Corporation; Johnson & Johnson Services, Inc.; 3M Healthcare; Integra LifeSciences; Erbe Elektromedizin GmbH; and Smith & Nephew. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
